Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer
Year: 1992
Type: article
Study design: Clinical Trial
Source: Cancer Immunology Immunotherapy
DOI: 10.1007/bf01741755
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
Award: G4394546720
OpenAlex ID: W2005477050
